Christian Weyer, EVP, Research & Development at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 3,162 shares at $123.24 ($390K) on 2019-12-27, disclosed to the SEC on 2019-12-30.
Open-market sale of $390k ICPT by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.24 | 1,581 | $195K | 50.0% |
| 2 | $123.24 | 1,581 | $195K | 50.0% |
| Total | $123.24 avg | 3,162 | $390K | 100% |
| Filing → |
| ICPT | SELL | 2020-01-27 | $136K | — | Filing → |
| ICPT | SELL | 2019-12-02 | $106K | — | Filing → |
| ICPT | SELL | 2019-11-27 | $623K | — | Filing → |